...
首页> 外文期刊>Journal of Endocrinology and Metabolism >Effects of the Switching From High-Purity Eicosapentaenoic Acid to Combination of Eicosapentaenoic Acid and Docosahexaenoic Acid on Metabolic Parameters: A Retrospective Longitudinal Study
【24h】

Effects of the Switching From High-Purity Eicosapentaenoic Acid to Combination of Eicosapentaenoic Acid and Docosahexaenoic Acid on Metabolic Parameters: A Retrospective Longitudinal Study

机译:高纯二十碳五烯酸转换为二十碳五烯酸和二十二碳六烯酸组合对代谢参数的影响:一项回顾性纵向研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Effects of the switching from high-purity eicosapentaenoic acid ester (hp-EPA) to n-3 fatty acid formulation containing EPA and docosahexaenoic acid (DHA) on metabolic parameters remain largely unknown.Methods: We retrospectively picked up patients who had been prescribed EPA + DHA for 2 months or longer after the prescription of hp-EPA for 2 months or longer between January 2010 and December 2015. We compared the data at baseline and at 2 months after the switching from hp-EPA to EPA + DHA.Results: Thirty-six patients were eligible for the analyses in our study. Serum triglyceride (TG) showed a non-significant decrease by approximately 9% after the switching. Serum TG showed a non-significant decrease by 24% and 10%, in the switching to the formulation including half daily dose of EPA and DHA and the formulation including the same daily dose of EPA and DHA, respectively. In patients who had shown a decrease in TG after the switching, serum TG at baseline was higher than that in patients who had shown an increase and non-change in TG after the switching. Further, in patients who had shown a decrease in TG after the switching to the formulation including the same daily dose of EPA and DHA, serum TG was significantly higher than that in patients who had shown an increase and non-change in TG. In the analysis of all patients, in patients with baseline TG ? 150 mg/dL, TG tended to decrease. In the analysis of patients who underwent the switching to the formulation including the same daily dose of EPA and DHA, in patients with baseline TG ? 150 mg/dL, TG significantly decreased.Conclusion: We studied effects of the switching from hp-EPA to EPA + DHA on metabolic parameters, and found that the switching is more effective to reduce TG in patients with higher TG levels at baseline.J Endocrinol Metab. 2016;6(3):75-79doi: http://dx.doi.org/10.14740/jem348w
机译:背景:从高纯度二十碳五烯酸酯(hp-EPA)转换为包含EPA和二十二碳六烯酸(DHA)的n-3脂肪酸制剂对代谢参数的影响仍然未知。在2010年1月至2015年12月之间,在hp-EPA处方2个月或更长时间后,处方2个月或更长时间的EPA + DHA。我们比较了从hp-EPA转换为EPA + DHA的基线和2个月时的数据。结果:36名患者符合我们研究的分析条件。切换后,血清甘油三酸酯(TG)下降了约9%,无明显下降。在切换到分别包含每日半剂量的EPA和DHA的制剂以及包含相同日剂量的EPA和DHA的制剂时,血清TG分别显示了24%和10%的显着降低。在切换后TG降低的患者中,基线时的血清TG高于切换后TG升高且未改变的患者。此外,在转用每日剂量相同的EPA和DHA的制剂后TG降低的患者,血清TG显着高于TG升高且未改变的患者。在所有患者的分析中,基线TG 150 mg / dL,TG倾向于降低。在对基线TG≥3的患者进行分析时,他们接受了每日更换相同剂量的EPA和DHA的制剂。结论:我们研究了从hp-EPA切换到EPA + DHA对代谢参数的影响,发现在基线时TG较高的患者,TG降低了150 mg / dL。内分泌代谢物。 2016; 6(3):75-79doi:http://dx.doi.org/10.14740/jem348w

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号